Sotera Health (SHC) Competitors $11.38 -0.23 (-1.98%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$11.38 0.00 (0.00%) As of 07:04 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SHC vs. HIMS, GH, OPCH, RDNT, BTSG, SGRY, PRVA, CON, WGS, and VCYTShould you be buying Sotera Health stock or one of its competitors? The main competitors of Sotera Health include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Surgery Partners (SGRY), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), GeneDx (WGS), and Veracyte (VCYT). These companies are all part of the "healthcare" industry. Sotera Health vs. Its Competitors Hims & Hers Health Guardant Health Option Care Health RadNet BrightSpring Health Services Surgery Partners Privia Health Group Concentra Group Holdings Parent GeneDx Veracyte Sotera Health (NASDAQ:SHC) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, media sentiment, profitability, dividends, valuation, institutional ownership and earnings. Is SHC or HIMS more profitable? Hims & Hers Health has a net margin of 9.24% compared to Sotera Health's net margin of 2.24%. Sotera Health's return on equity of 41.08% beat Hims & Hers Health's return on equity.Company Net Margins Return on Equity Return on Assets Sotera Health2.24% 41.08% 5.68% Hims & Hers Health 9.24%22.75%15.51% Which has better earnings and valuation, SHC or HIMS? Hims & Hers Health has higher revenue and earnings than Sotera Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSotera Health$1.10B2.94$44.34M$0.08142.25Hims & Hers Health$1.48B7.65$126.04M$0.6973.10 Which has more risk and volatility, SHC or HIMS? Sotera Health has a beta of 1.81, indicating that its share price is 81% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 2.02, indicating that its share price is 102% more volatile than the S&P 500. Do analysts recommend SHC or HIMS? Sotera Health currently has a consensus target price of $16.00, suggesting a potential upside of 40.60%. Hims & Hers Health has a consensus target price of $39.58, suggesting a potential downside of 21.53%. Given Sotera Health's stronger consensus rating and higher possible upside, analysts plainly believe Sotera Health is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sotera Health 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80Hims & Hers Health 3 Sell rating(s) 8 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.92 Does the media refer more to SHC or HIMS? In the previous week, Hims & Hers Health had 73 more articles in the media than Sotera Health. MarketBeat recorded 74 mentions for Hims & Hers Health and 1 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.77 beat Hims & Hers Health's score of 0.28 indicating that Sotera Health is being referred to more favorably in the media. Company Overall Sentiment Sotera Health Very Positive Hims & Hers Health Neutral Do institutionals & insiders hold more shares of SHC or HIMS? 91.0% of Sotera Health shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 55.1% of Sotera Health shares are owned by company insiders. Comparatively, 17.7% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummarySotera Health and Hims & Hers Health tied by winning 8 of the 16 factors compared between the two stocks. Get Sotera Health News Delivered to You Automatically Sign up to receive the latest news and ratings for SHC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SHC vs. The Competition Export to ExcelMetricSotera HealthMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.30B$7.25B$5.61B$9.29BDividend YieldN/A2.86%4.23%4.03%P/E Ratio142.2734.4428.5419.58Price / Sales2.9434.49429.2495.01Price / Cash9.6725.1136.0257.93Price / Book7.968.098.145.54Net Income$44.34M$236.06M$3.24B$257.73M7 Day Performance-1.98%-3.35%0.18%-0.08%1 Month Performance0.53%-0.38%5.96%8.09%1 Year Performance-11.78%19.35%26.24%13.02% Sotera Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SHCSotera Health3.1961 of 5 stars$11.38-2.0%$16.00+40.6%-6.9%$3.30B$1.10B142.273,000HIMSHims & Hers Health2.2293 of 5 stars$48.34+0.8%$39.58-18.1%+120.8%$10.74B$1.48B70.061,637Trending NewsInsider TradeGHGuardant Health4.4791 of 5 stars$49.54-1.9%$53.76+8.5%+52.5%$6.26B$739.02M-14.612,021Positive NewsAnalyst UpgradeOPCHOption Care Health4.4948 of 5 stars$30.91-0.8%$35.50+14.8%+2.1%$5.10B$5.00B24.938,088Positive NewsRDNTRadNet4.0771 of 5 stars$55.26-1.7%$69.60+26.0%-11.5%$4.22B$1.83B-128.5111,021BTSGBrightSpring Health Services1.7487 of 5 stars$22.00-0.5%$24.90+13.2%+77.2%$3.89B$11.27B78.5735,000SGRYSurgery Partners2.5 of 5 stars$22.03-0.5%$33.56+52.3%-15.2%$2.84B$3.11B-14.4015,000PRVAPrivia Health Group3.927 of 5 stars$21.35-3.4%$27.77+30.1%+14.9%$2.70B$1.74B177.931,140CONConcentra Group Holdings Parent2.8281 of 5 stars$20.33-1.1%$28.50+40.2%N/A$2.64B$1.90B15.1711,250WGSGeneDx3.7772 of 5 stars$85.74-6.4%$90.13+5.1%+136.8%$2.61B$330.14M-60.811,200Analyst DowngradeVCYTVeracyte3.562 of 5 stars$26.34-4.3%$40.90+55.3%+11.7%$2.15B$445.76M64.25790News CoveragePositive News Related Companies and Tools Related Companies Hims & Hers Health Competitors Guardant Health Competitors Option Care Health Competitors RadNet Competitors BrightSpring Health Services Competitors Surgery Partners Competitors Privia Health Group Competitors Concentra Group Holdings Parent Competitors GeneDx Competitors Veracyte Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SHC) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sotera Health Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Sotera Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.